Reannon Pharma Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Reannon Pharma Limited

Reannon Pharma Limited, a active public limited company, was established on 11 December 2017 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2017PLC302728. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.82 Cr.

Formerly known as Reannon Pharmaceuticals India Limited, Reannon Pharmaceuticals India Private Limited. It upholds a compliant status. Its leadership includes Shobha Gole Bhimrao (Director), Bhimrao Haribhau Gole (Director), Hrishikesh Bhimrao Gole (Director). Past directors included Bhimrao Haribhau Gole. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 407 L.B.S. Marg Nirmal Corporate Center Mulund, Mumbai, Maharashtra, 400080.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2017PLC302728

  • Registration Number

    302728

  • Incorporation Date

    11 December 2017

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹2.82 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 2.82 Cr
  • Company Age 8 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets **** 2.74%
Company report

Reannon Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Reannon Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Reannon Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Shobha Gole Bhimrao Director 11 Dec 2017 Current
Bhimrao Haribhau Gole Director 19 Mar 2019 Current
Hrishikesh Bhimrao Gole Director 11 Dec 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Reannon Pharma.

Reannon Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Reannon Pharma revenue growth over time
Reannon Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 2.74%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Reannon Pharma?

In 2022, Reannon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Reannon Pharma?

Unlock and access historical data on people associated with Reannon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Reannon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reannon Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Reannon Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Reannon Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Reannon Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Bhimrao Haribhau Gole was appointed as a Director was appointed as a Director on 19 Mar 2019 & has been associated with this company since 6 years 11 months . was completed.

  • Director Appointment

    Shobha Gole Bhimrao was appointed as a Director was appointed as a Director on 11 Dec 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Hrishikesh Bhimrao Gole was appointed as a Director was appointed as a Director on 11 Dec 2017 & has been associated with this company since 8 years 2 months . was documented.

  • Company Incorporation

    The activity Reannon Pharma Limited was registered on 11 Dec 2017 with Roc Mumbai & aged 8 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Reannon Pharma Limited?

The CIN of Reannon Pharma Limited is U74999MH2017PLC302728.

Where is Reannon Pharma Limited headquartered?

Reannon Pharma Limited is headquartered at Unit No. 407 L.B.S. Marg Nirmal Corporate Center Mulund, Mumbai, Maharashtra, 400080.

When was Reannon Pharma Limited incorporated?

Reannon Pharma Limited was incorporated on 11 December 2017.

Who are the current directors of Reannon Pharma Limited?

The current directors of Reannon Pharma Limited are

What is the primary industry of Reannon Pharma Limited?

The primary industry of Reannon Pharma Limited is Pharma.

Is Reannon Pharma Limited a listed company?

Reannon Pharma Limited is unlisted.

What is the capital structure of Reannon Pharma Limited?

The authorized capital of Reannon Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹2.82 Cr.

What is the compliance status of Reannon Pharma Limited?

The compliance status of Reannon Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available